Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 8 min ago
Peer-reviewedCC BYCancers

The Complex Biology of EIF3E (int6): From Its Original Discovery to EIF3E::RSPO2 Fusions in Solid Tumors and Lymphoma Susceptibility.

  1. 1Department of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy.

Abstract

Over the past three decades, the biology of EIF3E (int6) has emerged as far more complex than originally anticipated. Initially identified as a common integration site of Mouse Mammary Tumor Virus (MMTV) and subsequently recognized as a component of the eukaryotic translation initiation factor 3 (eIF3) complex, EIF3E is now understood as a multifunctional regulator involved in selective mRNA translation, proteostasis, genome stability, cellular stress responses, and tissue homeostasis. Recent studies have further extended this framework by demonstrating that conditional Eif3e deficiency promotes lymphoma susceptibility in mice, providing in vivo evidence linking EIF3E-dependent translational regulation to immune homeostasis and cancer development. This focused review retraces the scientific journey of EIF3E from its discovery as int6 to the progressive definition of its diverse biological functions and context-dependent roles in cancer. Particular attention is given to the historical relationship between int6 (EIF3E) and int7 (RSPO2), whose unexpected reunion in recurrent EIF3E::RSPO2 fusions in human solid tumors provides a unique bridge between classical retroviral insertional mutagenesis and contemporary cancer genomics. While transcriptional activation of RSPO2 through EIF3E regulatory elements represents the established oncogenic mechanism of the fusion, whether disruption of one EIF3E allele exerts additional biological effects remains unknown. Together, these observations highlight EIF3E as a nexus between selective translation, cellular homeostasis, and cancer, while emerging links between epigenomic, epitranscriptomic, and translational regulation open new perspectives for understanding its context-dependent functions in tumorigenesis.

Related

  1. Discovery of a molecular glue inhibitor that stabilises a non-productive Kalirin-Rac1 complex
    J. L. Gray, M. C. Callens, A. Henley +16
    bioRxivPreprintAll rights reservedFull textMolecular biology & gene regulationbioRxiv
  2. AlignMarkers: an original pipeline for placing molecular markers on physical sequences
    Camille Auneau, Baptiste Imbert, Mathieu Zemihi +3
    BMC BioinformaticsPeer-reviewedCC BYMolecular biology & gene regulationHAL
  3. Toward Ideal Proximity‐Driven Reactions in Chemical Biology
    Dominik Schauenburg
    Chembiochem : a European journal of chemical biologyPeer-reviewedCC BY-NCFull textMolecular biology & gene regulationEurope PMC
  4. From VALID principles to community standards in computational biology
    Yue Cao, Jean Y. H. Yang
    Quantitative BiologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMC
  5. GENETIC ASPECTS OF TELOMERE BIOLOGY DISORDERS
    Sophie de Tocqueville, Hélène Morel, Ibrahima Ba +2
    Revue des Maladies RespiratoiresPeer-reviewedPublisher termsFull text2 citedMolecular biology & gene regulationCell biologyHAL
BibTeX
@article{marchetti2026complex,
  title = {{The Complex Biology of EIF3E (int6): From Its Original Discovery to EIF3E::RSPO2 Fusions in Solid Tumors and Lymphoma Susceptibility.}},
  author = {Antonio Marchetti and Fiamma Buttitta},
  journal = {Cancers},
  year = {2026},
  month = sep,
  doi = {10.3390/cancers18193120},
  url = {https://europepmc.org/article/MED/42882815},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - The Complex Biology of EIF3E (int6): From Its Original Discovery to EIF3E::RSPO2 Fusions in Solid Tumors and Lymphoma Susceptibility.
AU  - Antonio Marchetti
AU  - Fiamma Buttitta
PY  - 2026
DA  - 2026/09/26
JO  - Cancers
DO  - 10.3390/cancers18193120
UR  - https://europepmc.org/article/MED/42882815
AB  - Over the past three decades, the biology of EIF3E (int6) has emerged as far more complex than originally anticipated. Initially identified as a common integration site of Mouse Mammary Tumor Virus (MMTV) and subsequently recognized as a component of the eukaryotic translation initiation factor 3 (eIF3) complex, EIF3E is now understood as a multifunctional regulator involved in selective mRNA translation, proteostasis, genome stability, cellular stress responses, and tissue homeostasis. Recent studies have further extended this framework by demonstrating that conditional Eif3e deficiency promotes lymphoma susceptibility in mice, providing in vivo evidence linking EIF3E-dependent translational regulation to immune homeostasis and cancer development. This focused review retraces the scientific journey of EIF3E from its discovery as int6 to the progressive definition of its diverse biological functions and context-dependent roles in cancer. Particular attention is given to the historical relationship between int6 (EIF3E) and int7 (RSPO2), whose unexpected reunion in recurrent EIF3E::RSPO2 fusions in human solid tumors provides a unique bridge between classical retroviral insertional mutagenesis and contemporary cancer genomics. While transcriptional activation of RSPO2 through EIF3E regulatory elements represents the established oncogenic mechanism of the fusion, whether disruption of one EIF3E allele exerts additional biological effects remains unknown. Together, these observations highlight EIF3E as a nexus between selective translation, cellular homeostasis, and cancer, while emerging links between epigenomic, epitranscriptomic, and translational regulation open new perspectives for understanding its context-dependent functions in tumorigenesis.
SN  - 2072-6694
ER  -